Author: healthadmin

Many medical devices must be sterilized for safe use. However, sterilizing pacemakers, catheters, and other devices with steam or heat can compromise their structural integrity. So medical device manufacturers turn to ethylene oxide, a compound that is highly effective at killing microorganisms at low concentrations and allows companies to meet the Food and Drug Administration’s strict sterility standards. As a result, approximately half of the medical devices in Japan are sterilized with ethylene oxide (EtO), which has become the cornerstone of the medical device industry. There’s just one problem. EtO is a toxic gas that has been linked to breast…

Exposure to diets high in fat and sugar during early development causes the brain to overreact to unhealthy foods in adulthood. This combination creates high levels of inflammation and reduces adaptive capacity within the brain’s main memory centers. These molecular changes suggest that the early nutritional environment has long-term effects on cognitive health, according to a recent study published in . nutritional neuroscience. The physical structure of the brain is not determined at birth. It constantly changes and adapts according to life experiences. This feature of the nervous system is known as neuroplasticity. Neuroplasticity allows humans and animals to form…

Genetic mutations that help animals such as yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing neurological damage in conditions such as cerebral palsy and multiple sclerosis (MS). The findings were published March 13 in the journal Cell Press neuronreveals a naturally occurring pathway that promotes regeneration after nerve injury, potentially opening new doors for treating diseases like MS by harnessing molecules already present in the human body. “Evolution is a great gift from nature, providing a variety of genes that help organisms adapt to different environments,” says corresponding author Liang Zhang of Songjiang Hospital,…

Clinically available KRAS inhibitors primarily target G12C, which is rare in PDAC and often develops resistance. Oncogenic KRAS inactivates RB1 through CDK4/6, but RB1 mutations are rare. Therefore, CDK4/6 inhibition provides an indirect strategy to combat KRAS-mediated malignancies without directly targeting KRAS. Virtually all pancreatic ductal adenocarcinomas (PDACs) result from activating mutations in the oncogene KRAS, which occurs in multiple different allelic forms. Although significant efforts have been made to develop inhibitors that target specific mutant KRAS proteins, the only drugs currently approved for clinical use are those that selectively target the KRASG12C variant. However, KRASG12C mutations are extremely rare…

An international team of researchers has achieved a breakthrough in the production of doxorubicin, an important chemotherapy agent. This research identifies and resolves a molecular “bottleneck” that has limited the drug’s natural production for more than 50 years. Doxorubicin is a chemotherapy drug that was first approved for medical use in the 1970s. It is the basis of treatment for a variety of cancers, including breast cancer, bladder cancer, lymphoma, and carcinoma, and more than 1 million patients are treated annually. However, bacteria naturally produce this important drug very inefficiently. As a result, the pharmaceutical industry has relied on expensive…

People under stress can have difficulty orienting themselves in space. Researchers from Bochum have discovered the reason. The stress hormone cortisol disrupts the brain’s navigation system. This impairs the function of grid cells, which play an important role in orientation. This was verified in an imaging study involving 40 people, including researchers at Ruhr University Bochum in Germany. Participants completed a virtual navigation experiment while their brain activity was recorded in an MRI scanner. If the subjects had been given cortisol before the experiment, their performance was even worse, obscuring the exact activity patterns of the grid cells. The results…

Macrophages are at the heart of mechanobiology research. The physical properties of macrophages, namely stiffness, adhesion, and ECM (extracellular matrix) sensing, are closely related to phenotypic polarization and immune function. Pro-inflammatory M1 macrophages typically exhibit higher cell stiffness, whereas anti-inflammatory tissue-repairing M2 macrophages are mechanically more flexible, and these mechanical properties determine how the cell responds to physical cues in the microenvironment. For decades, penstreptomycin has been used at a standard 1% v/v concentration in cell cultures to prevent bacterial contamination, but the effects of penstreptomycin on the mechanophenotype of macrophages, a mechanical property that defines cellular function, had never…

Recent research published in Journal of Applied Social Psychology This suggests that young men have a distorted view of the level of interest that other men have in careers in early childhood education and childcare. The findings provide evidence that sexual orientation stereotypes and misperceptions of peer beliefs further reinforce the shortage of men in caregiving roles. “Globally, men are grossly underrepresented in early childhood education and care. This is problematic for many reasons, but one of the main problems is that it reinforces the idea that care is a ‘women’s job’ (i.e. something that men cannot and should not…

Leading medical organizations on Friday recommended major changes to cardiovascular disease prevention, saying people as young as 40 to 30 should consider statins and other measures to manage cholesterol. Beyond just LDL (“bad”) cholesterol and statins, the latest recommendations take a more comprehensive approach to how and when to prevent and treat cardiovascular disease caused by hardening and narrowing of the arteries. In people without heart disease, if LDL (“bad”) cholesterol levels reach 160 mg/dL or higher starting in young adulthood at age 30, behavioral changes or additional medications are encouraged. That approach starts with a healthier lifestyle and can…

Pfizer CEO Dr. Albert Bourla has yet to surpass the $33 million he earned in 2022 for sales of the company’s COVID-19 blockbuster, but his $27.6 million compensation package isn’t too shabby after a busy 2025. Bourla’s 2025 compensation is his second-highest since taking the helm at Pfizer in 2019, topping last year’s $24.6 million. The CEO is credited with leading the pharmaceutical giant to “solid financial results” and setting the company up for “strong growth” toward the end of the decade, Pfizer said in its proxy statement (PDF). Pfizer had a busy year, with 2025 sales of $62.5 billion,…